Laurus Labs Completes Investment of INR833 Million in Joint Venture Company KRKA Pharma

MT Newswires Live

03-17

The Joint Corp.0.00%盤後

Laurus Labs (NSE:LAURUSLABS, BOM:540222) has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.

The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.

According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.

Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

no data

沒有相關數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2520255130"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2520255130\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2520255130?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-17 11:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2520255130","market":"sh","top_or_hot":-1,"title":"Laurus Labs Completes Investment of INR833 Million in Joint Venture Company KRKA Pharma","media":"MT Newswires Live","content":"<html><body><p> Laurus Labs (NSE:LAURUSLABS, BOM:540222) has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.</p><p>The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.</p><p>According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.</p><p>Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Laurus Labs Completes Investment of INR833 Million in Joint Venture Company KRKA Pharma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLaurus Labs Completes Investment of INR833 Million in Joint Venture Company KRKA Pharma\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-03-17 11:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Laurus Labs (NSE:LAURUSLABS, BOM:540222) has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.</p><p>The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.</p><p>According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.</p><p>Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4185","symbol_name":"保健護理機構","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2520255130","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2520255130","pubTimestamp":1742181966,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Laurus Labs  has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4185":"保健护理机构","JYNT":"The Joint Corp."},"translate_title":"Laurus Labs完成对合资公司KRKA Pharma的8.33亿印度卢比投资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JYNT":1},"content_text":"Laurus Labs (NSE:LAURUSLABS, BOM:540222) has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1}}}

如果下載按鈕點擊無跳轉，請點擊右上角菜單選擇 “在瀏覽器打開”

立即諮詢
下載APP
掃碼下載APP